People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lumena Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $51.4M | $1.6B | 2014 |
Ciara B. Kennedy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ciara B. Kennedy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Grey | 1 | 10 |
| David R. Savello | 1 | 2 |
| Howard E. Greene | 1 | 2 |
| John P McKearn | 1 | 2 |
| Alana B. McNulty | 1 | 2 |
| Rosina S. Maar Pavia | 1 | 1 |
| Ted S. Greene | 1 | 1 |
| Edward R. Mathers | 1 | 1 |
| Robert P. Alexander | 1 | 1 |
| Bradley T. Keller | 1 | 1 |
| Alejandro B. Dorenbaum | 1 | 1 |
| Susan E. Dube | 1 | 1 |
| Edward E. Greene | 1 | 1 |
| Ford S. Worthy | 1 | 1 |
| John E. McKearn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.